PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
165.3K views | +255 today
Follow

Understanding the rising expectations of highly digital health consumers 

From www.accenture.com

Highly-digital health consumers are more skeptical of healthcare transparency, eroding the professional authority of payers and providers.
No comment yet.

How Pharma Embraced Technology To Get Closer To Their Customers | Articles | Innovation

From channels.theinnovationenterprise.com

Through embracing new tech the healthcare and pharma industries have paved a way to create new and better experience for their digital-enabled customers
No comment yet.

Apple ResearchKit, Medical Research and Pharma Research Studies

From www.business2community.com

Apple’s ResearchKit has made great inroads into medical research studies that are open to a wide audience, do not require medical intervention and where participants can self-select and sign up.
No comment yet.

Les pansements aussi deviennent intelligents - Les Echos

From www.lesechos.fr

Urgo, numéro 3 européen dans les pansements, travaille au développement de sparadraps high-tech pour accélérer la cicatrisation des plaies chroniques. Une innovation médicalement et économiquement prometteuse.

No comment yet.

5 approaches for using technology to communicate with physicians

From www.clinical-innovation.com

As technology continues to weave its way into healthcare, more and more patients are using their smartphones and wearable devices to communicate with their doctors, according to a new study.

More than 58 percent of Americans have shared information with a medical professional through their smartphone, a mobile app or wearable device. One in four have emailed or texted a photo of a medical issue to a physician.

The study, released yesterday by communications firm Ketchum, surveyed 2,000 Americans that own a smartphone.

The survey revealed that many patients are managing their own health from smartphones and fitness trackers. Nearly 50 percent of survey respondents have an app that tracks fitness, exercise, health or medications, and 83 percent use these apps at least once a week.

"This study points to a shift in people's attitudes and readiness to use technology to manage their health," said Lisa Sullivan, executive vice president and North American technology practice leader for Ketchum, in a statement. "With U.S. smartphone adoption at 68 percent, now is the time for businesses that have a stake in the healthcare industry to push to develop approachable, intuitive mobile tech offerings that help the ever-increasing mobile user population improve something as personal and important as their health."

The researchers broke down the survey results and categorized respondents into five user profiles based on how much they used technology to keep track of their health.

Discerning Digitals: The most active users who are constantly connected, but still like face-to-face contact with medical professionals.

Swayable Seekers: A group of users that only uses their smartphone to make phone calls. They like to access and manage their health online, but still feel like they have a lot to learn about using technology to its full potential.

Health Tech Hesitators: This group generally is not happy with their health and physical well-being, and is not comfortable sharing medical information online.

App-athetic Agnostics: People that love using technology but don’t use it to manage their health, and don’t have plans to within the next year.

Low-tech Lifers: Traditionalists who don’t believe using technology to manage their health with benefit them.

 
 
 
No comment yet.

Le français Ipsen ne veut pas rater le train de la santé numérique

From www.latribune.fr

Peu investi dans la e-santé, comparé aux big pharma, le troisièm
No comment yet.

Pharma's access to docs declines as nonpersonal promotion increases

From www.mmm-online.com

Sales reps are now more likely to engage with physicians through nonpersonal promotion than in-person visits with doctors at their offices, a ZS report finds.
No comment yet.

Novartis to test digital coaching as adherence aid for clinical trials

From www.mobihealthnews.com

Can the success of digital health coaching apps like Twine Health and WellDoc be ported over to the clinical trial space?
No comment yet.

Industrie pharmaceutique & réseaux sociaux : 3 prérequis pour un mariage réussi.

From 1pharmacien2point0.wordpress.com

Si on pouvait visualiser la situation amoureuse sur Facebook, de l'industrie pharmaceutique et des réseaux sociaux, on pourrait lire certainement : "C'est compliqué". Pourtant, un mariage entre eux est bien envisageable ! Voici 3 prérequis, selon moi, pour que ce mariage se transforme en parfaite idylle.  Parmi les réticences à l’utilisation des réseaux sociaux par l'industrie…
No comment yet.

Diabète : tour d'horizon des solutions connectées pour aider les patients #DIABT1

From pharmageek.fr

On compte 300 000 diabétiques de type 1 en France, dont 10 000 enfants de moins de 15 ans. Une maladie auto-immune en augmentation constante.
No comment yet.

ComPaRe - Communauté de Patients pour la Recherche

From www.cohorte-compare.fr

ComPaRe est un projet scientifique collaboratif qui vise à accélérer la recherche sur les maladies chroniques en impliquant largement les patients.
No comment yet.

Roche lance une campagne digitale autour de la Fibrose pulmonaire idiopathique

From buzz-esante.fr

A l’occasion de la semaine mondiale de la fibrose pulmonaire idiopathique (FPI), le laboratoire lance une campagne digitale : Ensemble contre la FPI.
No comment yet.

Comment Sanofi et Google veulent lutter contre le diabète

From www.lesechos.fr

Les deux groupes donnent un contenu plus concret à l’alliance annoncée l’été dernier. Leur filiale Onduo va mettr
umanlife's curator insight, September 13, 3:46 AM

Comment Sanofi et Google comptent lutter contre le diabète ?

Johnson & Johnson Innovation pushes for digital health partnerships

From insight.ebdgroup.com

Johnson & Johnson sees digital health technology as one part of a larger mix of solutions as the industry moves toward precision medicine and a connected, patient-centered healthcare ecosystem.
No comment yet.

Johnson & Johnson collaboration uses 3D printing for futuristic medical devices

From www.medicalplasticsnews.com

Johnson & Johnson has teamed up with a subsidiary of HP to focus on personalisation of instrumentation and software for patient-specific healthcare devices.
No comment yet.

Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior

From medcitynews.com

$248 million in cash from Sanofi, and the same amount in a capital contribution by Verily (not in cash) have breathed life to a new company — Onduo — where the two equal partners will wage battle with a formidable enemy: diabetes.

That part — Google’s life science business and a well-known diabetes drug maker is collaborating to create a startup targeting type 2 diabetes patients initially — is clear.

However, what exactly the platform is and what products will emerge from this new company based in Cambridge, Massachusetts, is far from crystal clear.

Apparently even to the executives involved.

“The reality is that we don’t have a product to start with,” declared Joshua Riff, the CEO of Onduo, in a Google Hangouts interview from Germany, on Monday. “The exact product we don’t know what it is because we haven’t built it because we haven’t identified all the problems that we are trying to solve.”

That’s where the partnerships with Sutter Health in Northern California and Allegheny Health Network of western Pennsylvania come in. As Onduo builds modules that will ultimately be integrated into its platform, they can be tested for type 2 diabetes patients in a clinical care setting.
No comment yet.

Depressed? Pfizer Has an App (& Drug, of course) for That!

From www.pmlive.com

Pfizer has launched a new mobile app for patients suffering from depression that it hopes will enable them to take a more active role in managing their condition.
The firm wants its new Moodivator app to complement treatment and says it can do so in a simple and efficient way.
The free iPhone app allows patients to set goals, track their moods using a simple scale and share their progress with their care team.
It also includes information about one of Pfizer's prescription treatments for depression, but the company says the app is not intended to take the place of doctors' care or advice.
Pharma Guy's curator insight, September 14, 6:38 AM

I haven't seen this app yet, but I hope it includes all the necessary fair balance. See this PPT: “The Sorry State of Pharma Mobile Health Apps & What To Do About It”; http://sco.lt/4n05wH 

The Hard Truth About Business Model Innovation

From sloanreview.mit.edu

Successful business model innovation requires an understanding of how business models evolve.

Many attempts at business model innovation fail. To change that, executives need to understand how business models develop through predictable stages over time — and then apply that understanding to key decisions about new business models.

Understanding the interdependencies in a business model is important because those interdependencies grow and harden across time, creating another fundamental truth that is critical for leaders to understand: Business models by their very nature are designed not to change, and they become less flexible and more resistant to change as they develop over time. Leaders of the world’s best businesses should take special note, because the better your business model performs at its assigned task, the more interdependent and less capable of change it likely is. The strengthening of these interdependencies is not an intentional act by managers; rather, it comes from the emergence of processes that arise as the natural, collective response to recurrent activities. The longer a business unit exists, the more often it will confront similar problems and the more ingrained its approaches to solving those problems will become. We often refer to these ingrained approaches as a business’s “culture.”

 

rob halkes's curator insight, September 14, 10:25 AM

Great article about business model innovation. I was struck by the resemblances of errors made at introducing new value added services to pharmaceuticals, "beyond the pill". The same may possibly be expected by the new "hype" (?) about patient centricity: in my mind doing things without reflection about what it is: ending up in webinars/conferences existing mainly of either pharma staff in which they share their ignorance, or even in pharma staff added with a patient or patient representative, in which the patient is commonly canonized (as in 'sainted'): understandable but not a functional way of developing new trends in a company, let alone a new trend in a business sector..

See here what patients really have to say about corporate pharma companies and its patient "centricity": PatientView.com

Pfizer develops a mobile app to monitor depression

From www.internethealthmanagement.com

The app, called Moodivator and designed with help from the Virginia Commonwealth University of Medicine, includes features such as a mood tracker.
No comment yet.

Sanofi y Google se alían para ofrecer servicios de salud

From www.expansion.com

La farmacéutica francesa y Alphabet, matriz del gigante de Internet, desarrollarán dispositivos y servicios para el control de la diabetes. La farmacéutica francesa Sanofi y Verily Life Sciences (antes Google Life Sciences), filial de Alphabet, han creado la sociedad conjunta Onduo para el desarrollo de soluciones que combinen dispositivos, medicina, software y otros servicios dirigidos a mejorar la calidad de vida de las personas con diabetes. Esta nueva sociedad, un ejemplo más de los lazos que están surgiendo entre los sectores farmacéutico y tecnológico en el área de salud, tiene previsto invertir 500 millones de dólares. Entre los productos a la venta figurarán dispositivos conectados como plumas de insulina y servicios online. 

No comment yet.

Embracing digital transformation in the Pharma and Healthcare sectors

From econsultancy.com

Digital technology has increased the pace of change in consumer and patient expectations, but most pharma and healthcare organisations haven’t moved quickly in response.

Consumers are taking control over their own healthcare and driving change, preferring a more convenient way to get medical services and access information.

According to Deloitte Consulting, healthcare and pharma marketers spent just $1.4bn on digital ads, a figure that lags marketers in other industries.

One of the consequences of this digital underinvestment is that this has created opportunities for third parties to become the go-to resources for consumers and physicians looking for healthcare information online.

Our new Embracing Digital Transformation in the Pharma and Healthcare sectors reportlooks at the opportunities and challenges faced by organisations looking to respond to competition, and the changing needs of their customers and the approaches they are taking.   

The research is based on interviews with senior digital professionals across a range of pharmaceutical, biotech and consumer healthcare companies which included Alere Inc, Fermenta Biotech Limited, GSK Consumer Healthcare, MSD AP, Lenovo Health, Ogilvy Commonhealth Worldwide, Roche Products Limited and Takeda Pharmaceuticals. 

It was also supplemented with data from our own research looking at digital trends for 2016 and beyond, along with third party research.   

For more insight, Econsultancy subscribers can download the full report, but here are several key trends and insights emerging from the study. 

 

No comment yet.

Which Marketing Channels Have the Best ROI Measurability?

From www.marketingprofs.com

Metrics & ROI - Executives say email and search are the two marketing channels for which it is easiest to measure return on investment (ROI), according to recent research from Millward Brown.
No comment yet.

» Le Top 10 mondial des laboratoires pharmaceutiques en 2015 MyPharma Editions | L'Info Industrie & Politique de Santé

From www.mypharma-editions.com

Dans son dernier bilan économique et social sur l'industrie du médicament, le Leem fait le point sur le marché pharmaceutique mondial en 2015. Le groupe suisse Novartis, l’américain Pfizer et le français Sanofi arrivent en tête du top 10 des premières entreprises du secteur.
No comment yet.